| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |